Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.50
+0.01000.67%
Post-market: 1.500.00000.00%19:27 EDT
Volume:178.38K
Turnover:251.04K
Market Cap:3.71M
PE:-0.08
High:1.53
Open:1.46
Low:1.32
Close:1.49
52wk High:17.68
52wk Low:1.29
Shares:2.47M
Float Shares:2.40M
Volume Ratio:0.65
T/O Rate:7.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.2914
EPS(LYR):-74.1816
ROE:-154.77%
ROA:-70.04%
PB:-0.72
PE(LYR):-0.02

Loading ...

Crude Oil Down 2%; Abbott Shares Fall Following Q4 Results

Benzinga
·
Jan 23

Here’s Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today

TIPRANKS
·
Jan 22

Investors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-Bell

MT Newswires Live
·
Jan 22

60 Degrees Pharmaceuticals Partners with Runway Health to Expand Access to Malaria Prevention

Reuters
·
Jan 22

60 Degrees Pharmaceuticals Announces Partnership With Runway Health to Provide International Travelers Direct Access to Arakoda® for Malaria Prevention

THOMSON REUTERS
·
Jan 22

60 Degrees Pharmaceuticals Inc - Partnership With Runway Health Commences April 2, 2026

THOMSON REUTERS
·
Jan 22

60 Degrees Pharmaceuticals Announces 1-for-4 Reverse Stock Split

Reuters
·
Jan 22

60 Degrees Pharmaceuticals Inc trading halted, news pending

TIPRANKS
·
Jan 17

BRIEF-60 Degrees Pharmaceuticals, Inc. Announces Approval Of Reverse Stock Split Ratio

Reuters
·
Jan 15

60 Degrees Pharmaceuticals Announces 1-for-4 Reverse Stock Split

Reuters
·
Jan 15

60 Degrees Pharma outlines growth strategy in investor webinar

TIPRANKS
·
Jan 08

60 Degrees Pharmaceuticals Launches B-Free Study to Evaluate Tafenoquine for Chronic Babesiosis Fatigue

Reuters
·
Dec 29, 2025

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting With Chronic Fatigue in Peer-Reviewed, Sponsored Study at Nc State

THOMSON REUTERS
·
Dec 29, 2025

Geoffrey S. Dow, President and CEO, Acquires Common Shares of 60 Degrees Pharmaceuticals Inc

Reuters
·
Dec 17, 2025

Geoffrey S. Dow, President and CEO, Acquires Common Shares of 60 Degrees Pharmaceuticals Inc

Reuters
·
Dec 12, 2025

BRIEF-60 Degrees Pharmaceuticals Announces Expansion Of Arakoda Sales And Marketing In 2026

Reuters
·
Dec 11, 2025

60 Degrees Pharmaceuticals Announces Expansion of Arakoda® Sales and Marketing in 2026

THOMSON REUTERS
·
Dec 11, 2025

60 Degrees Pharmaceuticals Inc - to Add Clinical Sites for Babesiosis Trials

THOMSON REUTERS
·
Dec 11, 2025

60 Degrees Pharm Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Nov 28, 2025

BRIEF-60 Degrees Pharmaceuticals Announces Clinical Site Now Open For Patient Enrollment

Reuters
·
Nov 21, 2025